Queensland Bauxite Ltd (ASX:QBL) Medical Cannabis Import and Export Licences Secured
Queensland Bauxite Limited (ASX:QBL) is delighted to announce that Medcan Australia, has now been issued with both an Import & Export Licence under the ODC.
Companies in the News
Biotech
Queensland Bauxite Ltd (ASX:QBL) Revised Timetable for Notice of Meeting and Recompliance
As reported in the announcement released by Queensland Bauxite Limited (ASX:QBL) on 13th July 2018, the Notice of Meeting for the recompliance transactions is still being drafted and is yet to be reviewed by the ASX. The following table is the timeline to which the Company is currently working towards for the completion of the transactions and the recompliance requirements.
Queensland Bauxite Ltd (ASX:QBL) Shareholder Q and A
Since a Q&A on the ASX forum was announced (2 July '18), Queensland Bauxite Limited (ASX:QBL) has received many questions mainly by shareholders who were daunted by the 131 page announcement and are eager to understand further the Company's current strategy.
Regeneus Ltd (ASX:RGS) US Patent Office to Allow Key Patent for Progenza
Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the United States Patent Office has issued a notice of allowance for issuance of a patent covering the composition and use of Progenza.
Regeneus Ltd (ASX:RGS) Update on Licensing Progenza in Japan
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced it was on track to complete its clinical collaboration with a Japanese partner for Progenza in Japan in the near-term. The company had disclosed that it anticipated completing the collaboration before the end of 30 June but discussions have taken longer than originally anticipated.
Queensland Bauxite Ltd (ASX:QBL) Note to Shareholders from the Executive Chairperson, Mrs Pnina Feldman
It is obvious by the many genuine questions and observations from shareholders to Queensland Bauxite (ASX:QBL) that although six weeks was spent both by the company and ASX to make sure that the company merger/re-compliance announcement informed shareholders to the maximum, nevertheless there are still questions arising from the lengthy announcement which some shareholders feel need to be addressed.
Regeneus Ltd (ASX:RGS) Grant of ASX Waiver
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced it has entered into an R&D loan facility agreement with Paddington St Finance. The maximum loan value of the facility is the lesser of $2 million or 80% of the estimated refundable tax offset credits under the ATO's R&D tax incentive.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
Social Media
